Video

On Cancer, Lynch Syndrome and Soccer

Author(s):

Despite three bouts with cancer, David Dubin still continued to play soccer. Now, not only is he persevering on the soccer field, but in the field of cancer as well. Dubin and his wife, Robin, founded AliveAndKickin. This organization works toward bettering the lives of people like Dubin who have Lynch Syndrome, which gives a genetic predisposition to cancer.

Despite three bouts with cancer, David Dubin still continues to play soccer. Now, not only is he persevering on the soccer field, but in the field of cancer as well. Dubin and his wife, Robin, founded AliveAndKickin, an organization working toward improving the lives of people like Dubin who have Lynch Syndrome, which gives a genetic predisposition to cancer, and their families.

AliveAndKickin recently launched the HEROIC Registry, a patient-centered database of information for people who have a higher hereditary risk of developing cancer.

Related Videos
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Dr. Laura Dawson, a professor and chair of the department of Radiation Oncology at the University of Toronto, and a practicing radiation oncologist in the Radiation Medicine Program at Princess Margaret Cancer Center, University Health Network in Toronto.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Michael Bogenschutz, director of the NYU Langone Center for Psychedelic Medicine in New York,
Dr. Richard “Rick" Winneker
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
Image of man with grey hair.
Image of woman with blonde hair.
Image of man with grey hair.